 |
ACR Image Metrix: An imaging contract research organization (CRO) located in the American College of Radiology Clinical Research Center in Philadelphia, applies imaging techniques to improve the efficiency of drug and medical device development programs. The world-class team of radiologists and imaging scientists at ACR Image Metrix work with pharmaceutical, biotech and medical device companies to integrate the appropriate imaging technologies, modalities and clinical design techniques into their imaging studies. ACR Image Metrix has years of experience utilizing state-of-the-art technologies to provide a complete line of imaging services from site qualification and training, study initiation, image management, reader studies and much more.
www.acr-imagemetrix.net
|
 |
Applied Clinical Intelligence: Applied Clinical Intelligence provides decision makers with the trusted information they need to clearly communicate the value and safety of medical treatments, drugs and devices. Applied Clinical Intelligence enables pharmaceutical, biotechnology, medical device and health care customers to realize process efficiencies and resulting savings in cost and time.
www.a-ci.com
|
 |
California Clinical Trials (CCT): Since 1983, California Clinical Trials (CCT) has been at the forefront of drug development. CCT's best-in-class clinical experts, research staff and trained physicians all work together seamlessly to bring hope to patients around the world. Whether providing careful patient selection for Phase I studies, or experience in drug development and research for Phase II-IV operations, CCT quality and performance allow clients to make "go/no-go" decisions about your products.
www.cctrials.com
|
 |
Cetero Research: Cetero research is an industry leading contract research organization (CRO) in early-stage research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies- more than any other CRO. In addition, Cetero's cardiac safety experience spans more than 50 TQT trials, with the largest trial to-date including 280 participants. Cetero's proven track record allows the company to provide flexible and high-quality drug development services, and its time-tested systems produce consistent and reliable data clients can trust. Cetero's clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Cetero's bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules.
www.cetero.com
|
 |
ChanTest: ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately, help make better, safer drugs. The preeminent ion channel services company, ChanTest serves its drug discovery and development customers with GLP (Good Laboratory Practice) safety assays and automated-profiling assays, using its library of ion channel-expressing cell lines.
www.chantest.com
|
 |
Charles River: For more than 60 years Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical and clinical support services. Our offerings span the entire drug development process, from discovery through market approval, providing our clients a seamless partnership throughout.
www.criver.com
|
 |
Comprehensive Phase One ®: Since 1995 Comprehensive Phase One® (CPO) ® has successfully conducted more than 500 Phase 1-2a studies. With its new state-of-the-art 120-bed research clinic in Miramar, Florida, recently renovated 60-bed unit in Fort Myers, FL, and its validated electronic source document system, our experienced team of Phase I professionals provide clients with quality data, rapid enrollment and superior customer service. Through sister company, Comprehensive Drug Development TM, Comprehensive Drug DevelopmentTM, CPO provides full complete services for early clinical studies including project management, data management (featuring the EXPERT Technology Platform), biostatistics, medical writing and clinical and medical monitoring.
Comprehensive Phase One
|
 |
DecisionLine Clinical Research: DecisionLine Clinical Research, a CRO, provides early-stage development expertise to pharmaceutical and biotechnology companies. While experienced with many therapeutic areas, DecisionLine has significant domain expertise on measuring the drug effect of CNS (central nervous system) products.
www.decisionlinecrc.com
|
 |
ICON Clinical Research, Inc.: ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.
www.iconclinical.com
|
 |
PAREXEL: PAREXEL is a leading global biopharmaceutical services organization that helps clients expedite time-to-market through development and launch services. These include a broad range of clinical-development capabilities, integrated advanced technologies, regulatory-affairs consulting and commercialization services.
www.parexel.com
|
 |
Seaview Research, Inc. : SeaView Research provides Phase I and early Phase II clinical pharmacology testing to the pharmaceutical and biotech industries. SeaView prides itself in performing the most demanding and complex protocols while maintaining uncompromising standards of quality, integrity, and timeliness. We offer exceptional client-focused service led by a full-time staff of more than 160 employees including three board certified physicians, physicians assistant, a registered dietician, 2 pharmacists, and ACRP certified RN study coordinators. Our medical staff is highly experienced in the intricacies of thorough QT / QTc studies, having performed over 20 such studies in the past 5 years.
www.seaviewresearch.net
|
 |
South Texas Accelerated Research Therapeutics: (START) is located in San Antonio. Its mission is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. START consists of a team of highly trained physicians and staff with extensive experience in Phase I clinical trials research. In 2008, START expanded globally with the launch of START Madrid which aims to keep the development of anticancer agents operating 24 hours a day. Because of the work of scientists like those at START, and the continuing advances in technology, real progress is being made against cancer and we are able to improve the tools to understand, detect, and diagnose cancer. Today, people with cancer are living longer than ever before with a better quality of life.
www.startthecure.com
|
 |
Swiss Pharma Contract, Ltd.: As an International CRO, Swiss Pharma Contract, Ltd. offers a variety of services focused on clinical pharmacology and clinical research, ranging from first testing of a new drug in man to post-marketing clinical studies.
www.pharmacontract.ch
|
